Drugs & medicalClass II

Rising Pharma Holding, Inc. recalls Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings,…

Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and…

Read the official notice →
Date
2025-10-22
Country
United States
Brand
Rising Pharma Holding
Product
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc.…
Classification
Class II
Units
Distributed Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Rising Pharma Holding recalls

  1. 2026-07-29
  2. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc.,…

    Presence of Precipitate: medication was crystallizing and particles floating in the bottle

    FDA · DrugRising Pharma Holding, Inc.Nationwide U.S.A.Official notice →
  3. 2026-03-11
  4. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

    Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the U.SOfficial notice →
  5. 2025-03-26
  6. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USA.Official notice →
  7. 2025-01-15
  8. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only,…

    CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRising Pharma Holding, Inc.NationwideOfficial notice →
  9. 2024-12-11
  10. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99)…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit

    FDA · DrugRising Pharma Holding, Inc.Nationwide.Official notice →
  11. 2024-07-17
  12. US
    Drugs & medicalClass III

    Rising Pharma Holding, Inc. recalls Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising…

    Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USAOfficial notice →
All 9 Rising Pharma Holding recalls →

Other drugs & medical recalls in the United States

  1. 2025-10-22
  2. US
    Drugs & medicalClass I

    Olympus Corporation of the Americas recalls EVIS EXERA BRONCHOVIDEOSCOPE OLYMPUS BF TYPE XT160

    Additional IFU updates to provide further clarification on safe and effective use of bronchoscopes when used in conjunction with laser, argon plasma coagulation, and high-frequency therapy equipment.

    FDA · DeviceOlympus Corporation of the AmericasUS Nationwide Distribution.Official notice →
  3. US
    Drugs & medicalClass I

    Cook Medical Incorporated recalls Zenith Alpha 2 Thoracic Endovascular Graft, Catalog Prefix ZTA2- Reference Part Numbers ZTA2-P-40-117-W ZTA2-P-40-167 ZTA2-P-40-167-W…

    Affected devices may contain PTFE coating scrapings. Scrapings could be released during device deployment, potentially causing intravascular embolization.

    FDA · DeviceCook Medical IncorporatedDomestic distribution to AL AR AZ CA CT DC DE FL GA IL IN LA MA MD MI MN MO NC…Official notice →
  4. US
    Drugs & medicalClass I

    Percussionaire Corporation recalls Phasitron 5, IPV In-Line Valve, (Intrapulmonary Percussive Ventilation) REF: P5-TEE-20 (pack of 20)/ P5-TEE (individual) with In-Line…

    IFU update; in-line valve, with pressure relief seal may leak when used with ventilator; don't use in neonates/infants, with target tidal volumes less-than50mL or less-than10kg- at high risk of…

    FDA · DevicePercussionaire CorporationWorldwide distribution. US nationwide, Russia, Japan, Switzerland, Canada,…Official notice →
  5. US
  6. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217,…

    CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity…

    FDA · DrugAmerisource Health Services LLCNationwide within the United StatesOfficial notice →
  7. US
    Drugs & medicalClass III

    Endo USA, Inc. recalls Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par…

    Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

    FDA · DrugEndo USA, Inc.Nationwide within the United StatesOfficial notice →
See all drugs & medical recalls →